Dr. Mohyeldin completed his undergraduate education at Emory University with a degree in neuroscience and behavioral biology. Having been selected as an All-American Athlete, he was drafted to play professional soccer in Atlanta prior to medical school.
Dr. Mohyeldin completed his medical education at George Washington University. During medical school he was awarded a grant from the American Association of Neurological Surgeons and from the Maryland Stem Cell Research Fund to pursue a post-doctoral research fellowship at Johns Hopkins University under the mentorship of Dr. Alfredo Quinones-Hinojosa.
His research investigated developmental transcriptional programs coopted by brain cancer with a specific focus on chordomas and glioblastomas. During this time, he developed the first animal model for chordoma and identified the transcription factor brachyury as a novel therapeutic target, which is currently the focus of a major NIH clinical trial as well as multiple drug design studies for chordoma patients.
Dr. Mohyeldin pursued his neurosurgical training at Ohio State University, during that time he was awarded the R25 grant from NIH to further pursue this work. After completing his residency, he remained at OSU and pursued a clinical fellowship with Dr. Daniel Prevedello and Ricardo Carrau in advanced skull base and endoscopic cranial surgery.
He comes to the Neurosurgery Department to work with Dr. Juan Fernandez-Miranda and collaborate with leading basic scientists at Stanford to identify and target important transcriptional programs that maintain cancer stem cell populations in chordoma to find a meaningful cure for this disease.